INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,320 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
TN
Tanious Jubran N.President & COO
SVVSavers Value Village, Inc.
Tax withholding
F$58K
7,244 sh
Mar 12, 2026Mar 16, 2026
Page 1138 of 1758
← PrevNext →
traded Mar 12, 2026
+4d
SEC Form 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Option exercise
M$200K
48.9K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

8
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$174K
6,348 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

8
PC
Pledger Thomas ChristopherCHIEF FINANCIAL OFFICER
WESTWestrock Coffee Co
Tax withholding
F$56K
13.1K sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC Form 4

Evidence

8
CC
Cochran CarolineDirector, Co-Founder, COO, 10% Owner
OKLOOklo Inc.
Option exercise
M$309K
5,191 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

8
DJ
DeWitte JacobDirector, Co-Founder, CEO, 10% Owner
OKLOOklo Inc.
Option exercise
M$309K
5,191 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

8
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Option exercise
M$200K
48.9K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

6
WL
Wu LeiDirector, Chief Executive Officer, 10% Owner
GCTGigaCloud Technology Inc
Open-market sale · 10b5-1 plan
SELL$130K
3,098 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

6
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$160K
8,456 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

5
TN
Tanious Jubran N.President & COO
SVVSavers Value Village, Inc.
Grant or award
A—
76.9K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

5
TN
Tanious Jubran N.President & COO
SVVSavers Value Village, Inc.
Grant or award
A—
16.4K sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

5
FA
Ford William ACHIEF OPERATING OFFICER
WESTWestrock Coffee Co
Tax withholding
F$42K
9,806 sh
Mar 15, 2026Mar 16, 2026
traded Mar 15, 2026
+1dSEC Form 4

Evidence

5
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Option exercise
M$15.76
4 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

5
MK
McCulloch KevinSee Remarks
XERSXeris Biopharma Holdings, Inc.
Option exercise
M$15.76
4 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

5
AA
Asmerom AmineChief Accounting Officer
CHYMChime Financial, Inc.
Grant or award
A—
75.0K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

5
NS
Newcomb Matthew SChief Financial Officer
CHYMChime Financial, Inc.
Grant or award
A—
281.4K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

5
HE
Hughes Edmond E. Jr.Ex VP & Chief HR Officer
HIIHUNTINGTON INGALLS INDUSTRIES, INC.
Grant or award
A—
7 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

5
CD
Chewning Eric D.EVP, Maritime Sys & Corp STR
HIIHUNTINGTON INGALLS INDUSTRIES, INC.
Grant or award
A—
7 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

5
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Option exercise
M—
40.0K sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

5
BR
Britt Christopher RDirector, Chief Executive Officer
CHYMChime Financial, Inc.
Grant or award
A—
900.6K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

5
SS
Steves SeanSr VP & COO of SW Ops
CWSTCASELLA WASTE SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$8,702
97 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

3
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
6,348 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

3
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
1,754 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

3
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
2,985 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

2
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$216K
2,985 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

2
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$121K
4,125 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

1
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$84K
3,079 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

1
SS
Steves SeanSr VP & COO of SW Ops
CWSTCASELLA WASTE SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$17K
197 sh
Mar 16, 2026Mar 16, 2026
traded Mar 16, 2026
+0dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
4,167 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
3,542 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

0
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
8,456 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$59K
4,167 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$36K
3,542 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

0
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$49K
1,754 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$6,856
6,348 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC Form 4

Evidence

0
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$7,038
253 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC Form 4

Evidence

56
NR
Nielson Brandon R.Director
NANAKeystone Private Income Fund
Open-market purchase
BUY$10.00M
101.5K sh
Mar 1, 2026Mar 13, 2026
traded Mar 1, 2026
+12dSEC Form 4

Evidence

50
DD
Dorosh DmitriyPrincipal Accounting Officer
APPAppLovin Corp
Open-market sale
SELL$1.14M
2,509 sh
Mar 13, 2026Mar 13, 2026
traded Mar 13, 2026
+0dSEC Form 4

Evidence

48
HA
Helfert AdrianCIO, Multi-Asset Inv.
WHGWESTWOOD HOLDINGS GROUP INC
Open-market sale
SELL$175K
10.8K sh
Feb 23, 2026Mar 13, 2026
traded Feb 23, 2026
+18dSEC Form 4

Evidence

48
LM
Lockridge MatthewHead, U.S. Value Inv.
WHGWESTWOOD HOLDINGS GROUP INC
Open-market sale
SELL$87K
5,379 sh
Feb 23, 2026Mar 13, 2026
traded Feb 23, 2026
+18dSEC Form 4

Evidence